162 related articles for article (PubMed ID: 36932973)
1. Methylation Profile of Cancer Testis Antigens in Colorectal Cancer.
Abu N; Rus Bakarurraini NAA; Nasir SN; Ishak M; Baharuddin R; Jamal R; Ab Mutalib NS
Iran J Immunol; 2023 Mar; 20(1):83-91. PubMed ID: 36932973
[TBL] [Abstract][Full Text] [Related]
2. Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.
Kim R; Kulkarni P; Hannenhalli S
BMC Cancer; 2013 Mar; 13():144. PubMed ID: 23522060
[TBL] [Abstract][Full Text] [Related]
3. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
4. The potential immune-eliciting cancer testis antigens in colorectal cancer.
Chi Soh JE; Abu N; Jamal R
Immunotherapy; 2018 Sep; 10(12):1093-1104. PubMed ID: 30185136
[TBL] [Abstract][Full Text] [Related]
5. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
7. A new high-throughput screening methodology for the discovery of cancer-testis antigen using multi-omics data.
Li D; Xia L; Zhang X; Liu Y; Wang Z; Guo Q; Huang P; Leng W; Qin S
Comput Methods Programs Biomed; 2024 Jun; 250():108193. PubMed ID: 38678957
[TBL] [Abstract][Full Text] [Related]
8. Cancer/testis-associated genes: identification, expression profile, and putative function.
Zendman AJ; Ruiter DJ; Van Muijen GN
J Cell Physiol; 2003 Mar; 194(3):272-88. PubMed ID: 12548548
[TBL] [Abstract][Full Text] [Related]
9. Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets.
Xie K; Fu C; Wang S; Xu H; Liu S; Shao Y; Gong Z; Wu X; Xu B; Han J; Xu J; Xu P; Jia X; Wu J
J Ovarian Res; 2019 Jan; 12(1):1. PubMed ID: 30609934
[TBL] [Abstract][Full Text] [Related]
10. Cancer-testis antigens in canine histiocytic sarcoma and other malignancies.
Nemec PS; Kapatos A; Holmes JC; Stowe DM; Hess PR
Vet Comp Oncol; 2019 Sep; 17(3):317-328. PubMed ID: 30854786
[TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
Djureinovic D; Dodig-Crnković T; Hellström C; Holgersson G; Bergqvist M; Mattsson JSM; Pontén F; Ståhle E; Schwenk JM; Micke P
Lung Cancer; 2018 Nov; 125():157-163. PubMed ID: 30429015
[TBL] [Abstract][Full Text] [Related]
12. Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications.
Tarnowski M; Czerewaty M; Deskur A; Safranow K; Marlicz W; Urasińska E; Ratajczak MZ; Starzyńska T
Dis Markers; 2016; 2016():1987505. PubMed ID: 27635108
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs.
Lian Y; Meng L; Ding P; Sang M
Clin Epigenetics; 2018 Sep; 10(1):115. PubMed ID: 30185218
[TBL] [Abstract][Full Text] [Related]
14. Inducible expression of cancer-testis antigens in human prostate cancer.
Heninger E; Krueger TE; Thiede SM; Sperger JM; Byers BL; Kircher MR; Kosoff D; Yang B; Jarrard DF; McNeel DG; Lang JM
Oncotarget; 2016 Dec; 7(51):84359-84374. PubMed ID: 27769045
[TBL] [Abstract][Full Text] [Related]
15. Cancer-testis antigens: the current status on antigen regulation and potential clinical use.
Lim SH; Zhang Y; Zhang J
Am J Blood Res; 2012; 2(1):29-35. PubMed ID: 22432085
[TBL] [Abstract][Full Text] [Related]
16. Expression of cancer/testis antigens in prostate cancer is associated with disease progression.
Suyama T; Shiraishi T; Zeng Y; Yu W; Parekh N; Vessella RL; Luo J; Getzenberg RH; Kulkarni P
Prostate; 2010 Dec; 70(16):1778-87. PubMed ID: 20583133
[TBL] [Abstract][Full Text] [Related]
17. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
Bodey B
Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
[TBL] [Abstract][Full Text] [Related]
18. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
Gordeeva O
Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
[TBL] [Abstract][Full Text] [Related]
19. Melanoma: a prototype of cancer-testis antigen-expressing malignancies.
Faramarzi S; Ghafouri-Fard S
Immunotherapy; 2017 Oct; 9(13):1103-1113. PubMed ID: 29032737
[TBL] [Abstract][Full Text] [Related]
20. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
Nin DS; Deng LW
Cells; 2023 Mar; 12(6):. PubMed ID: 36980267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
